Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tarkan Karakan, Aycan Gundogdu, Hakan Alagözlü, Nergiz Ekmen, Seckin Ozgul, Varol Tunali, Mehmet Hora, Damla Beyazgul & O. Ufuk Nalbantoglu. (2022) Artificial intelligence-based personalized diet: A pilot clinical study for irritable bowel syndrome. Gut Microbes 14:1.
Read now
Read now
Articles from other publishers (36)
Heyong Tang, Xiaoqi Chen, Shun Huang, Gang Yin, Xiyang Wang & Guoming Shen. (2023) Targeting the gut–microbiota–brain axis in irritable bowel disease to improve cognitive function – recent knowledge and emerging therapeutic opportunities. Reviews in the Neurosciences 0:0.
Crossref
Crossref
Kaveh Naseri, Hossein Dabiri, Meysam Olfatifar, Mohammad Amin Shahrbaf, Abbas Yadegar, Mona Soheilian-Khorzoghi, Amir Sadeghi, Saeede Saadati, Mohammad Rostami-Nejad, Anil K. Verma & Mohammad Reza Zali. (2023) Evaluation of gut microbiota of iranian patients with celiac disease, non-celiac wheat sensitivity, and irritable bowel syndrome: are there any similarities?. BMC Gastroenterology 23:1.
Crossref
Crossref
Silvia Cristina Vergara, María José Leiva, María Victoria Mestre, Fabio Vazquez, María Cristina Nally & Yolanda Paola Maturano. (2023)
Non-
saccharomyces
yeast probiotics: revealing relevance and potential
. FEMS Yeast Research 23.
Crossref
Crossref
Geetika M. Ahlawat & Prabhat K. Singh. (2023) Methods of Determining Irritable Bowel Syndrome and Efficiency of Probiotics in Treatment: A Review. Current Therapeutic Research 99, pages 100721.
Crossref
Crossref
Vicente Navarro-López, Adriana Hernández-Belmonte, Maria Isabel Pérez Soto, Maikel Ayo-González, Guillermo Losa-Rodríguez, Esther Ros-Sánchez, Maravillas Martínez-Gabarrón, Pedro Sánchez-Pellicer, Juan Aguera-Santos, Eva Núñez-Delegido, Beatriz Ruzafa-Costas, José Antonio Picó-Monllor & Laura Navarro-Moratalla. (2022) Oral intake of Kluyveromyces marxianus B0399 plus Lactobacillus rhamnosus CECT 30579 to mitigate symptoms in COVID-19 patients: A randomized open label clinical trial. Medicine in Microecology 14, pages 100061.
Crossref
Crossref
Klaudia Ustianowska, Łukasz Ustianowski, Filip Machaj, Anna Gorący, Jakub Rosik, Bartosz Szostak, Joanna Szostak & Andrzej Pawlik. (2022) The Role of the Human Microbiome in the Pathogenesis of Pain. International Journal of Molecular Sciences 23:21, pages 13267.
Crossref
Crossref
Sara Elosegui, Jaime López-Seoane, María Martínez-Ferrán & Helios Pareja-Galeano. (2022) Interaction Between Caffeine and Creatine When Used as Concurrent Ergogenic Supplements: A Systematic Review. International Journal of Sport Nutrition and Exercise Metabolism 32:4, pages 285-295.
Crossref
Crossref
Giorgia Perpetuini, Yves Waché & Rosanna Tofalo. 2022. Probiotics, Prebiotics and Synbiotics. Probiotics, Prebiotics and Synbiotics
103
121
.
N. V. Gonchar, G. G. Alekhina, A. N. Tsapieva, A. N. Suvorov, E. I. Ermolenko, N. S. Lavrenova, S. G. Grigoriev, Y. V. Lobzin, N. V. Skripchenko, A. I. Khavkin, K. D. Ermolenko & S. Kim. (2022) Personalized symbiontic therapy for children with functional digestive disorders. Experimental and Clinical Gastroenterology:12, pages 44-52.
Crossref
Crossref
Kaveh Naseri, Hossein Dabiri, Mohammad Rostami-Nejad, Abbas Yadegar, Hamidreza Houri, Meysam Olfatifar, Amir Sadeghi, Saeede Saadati, Carolina Ciacci, Paola Iovino & Mohammad Reza Zali. (2021) Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome. BMC Gastroenterology 21:1.
Crossref
Crossref
Riccardo Vasapolli, Christian Schulz, Melanie Schweden, Christina Casèn, Graceline Tina Kirubakaran, Katrine Hånes Kirste, Lukas Macke, Alexander Link, Kerstin Schütte & Peter Malfertheiner. (2021) Gut microbiota profiles and the role of anti‐CdtB and anti‐vinculin antibodies in patients with functional gastrointestinal disorders (FGID). European Journal of Clinical Investigation 51:12.
Crossref
Crossref
N. V. Gonchar, G. G. Alexina & A. N. Suvorov. (2021) “Old” and “new” probiotics in the treatment of gastroenterological diseases in children and adults: how to increase effectiveness?. Experimental and Clinical Gastroenterology:3, pages 194-206.
Crossref
Crossref
Piotr Dubinski, Katarzyna Czarzasta & Agnieszka Cudnoch-Jedrzejewska. (2021) The Influence of Gut Microbiota on the Cardiovascular System Under Conditions of Obesity and Chronic Stress. Current Hypertension Reports 23:5.
Crossref
Crossref
Annamaria Altomare, Claudia Di Rosa, Elena Imperia, Sara Emerenziani, Michele Cicala & Michele Pier Luca Guarino. (2021) Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms. Nutrients 13:5, pages 1506.
Crossref
Crossref
Arnold Berstad, Olav Hauso, Ketil Berstad & Johanna E.R. Berstad. (2020) From IBS to ME – The dysbiotic march hypothesis. Medical Hypotheses 140, pages 109648.
Crossref
Crossref
Rapat Pittayanon, Jennifer T. Lau, Yuhong Yuan, Grigorios I. Leontiadis, Frances Tse, Michael Surette & Paul Moayyedi. (2019) Gut Microbiota in Patients With Irritable Bowel Syndrome—A Systematic Review. Gastroenterology 157:1, pages 97-108.
Crossref
Crossref
Jiazhong Wang, Hongyan Zhang, Huijie Du, Fangkun Wang, Hongmei Li & Xiaomin Zhao. (2019) Identification and characterization of Diutina rugosa SD-17 for potential use as a probiotic. LWT 109, pages 283-288.
Crossref
Crossref
Fernando Rizzello, Chiara Ricci, Michela Scandella, Elena Cavazza, Elisabetta Giovanardi, Maria Chiara Valerii, Massimo Campieri, Antonietta Comparone, Luigia De Fazio, Marco Candela, Silvia Turroni & Enzo Spisni. (2018) Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study. BMC Complementary and Alternative Medicine 18:1.
Crossref
Crossref
Hirokazu Fukui, Xin Xu & Hiroto Miwa. (2018) Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders. Journal of Neurogastroenterology and Motility 24:3, pages 367-386.
Crossref
Crossref
Valeria D. Felice & Siobhain M. O'Mahony. (2017) The microbiome and disorders of the central nervous system. Pharmacology Biochemistry and Behavior 160, pages 1-13.
Crossref
Crossref
Giovanni Barbara, Eleonora Scaioli, Maria Raffaella Barbaro, Elena Biagi, Luca Laghi, Cesare Cremon, Giovanni Marasco, Antonio Colecchia, Gianfranco Picone, Nunzio Salfi, Francesco Capozzi, Patrizia Brigidi & Davide Festi. (2017) Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease. Gut 66:7, pages 1252-1261.
Crossref
Crossref
Hai-Ning Liu, Hao Wu, Yu-Zhuo Chen, Yan-Jie Chen, Xi-Zhong Shen & Tao-Tao Liu. (2017) Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis. Digestive and Liver Disease 49:4, pages 331-337.
Crossref
Crossref
Xiaojun Zhuang, Lishou Xiong, Li Li, Manying Li & Minhu Chen. (2017) Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis. Journal of Gastroenterology and Hepatology 32:1, pages 28-38.
Crossref
Crossref
Maria Elisabetta Fadda, Valentina Mossa, Maura Deplano, Maria Barbara Pisano & Sofia Cosentino. (2017) In vitro screening of Kluyveromyces strains isolated from Fiore Sardo cheese for potential use as probiotics. LWT 75, pages 100-106.
Crossref
Crossref
Sara Quarella, Paola Lovrovich, Simone Scalabrin, Ilenia Campedelli, Ana Backovic, Veronica Gatto, Federica Cattonaro, Alessandro Turello, Sandra Torriani & Giovanna E. Felis. (2016)
Draft Genome Sequence of the Probiotic Yeast Kluyveromyces marxianus
fragilis
B0399
. Genome Announcements 4:5.
Crossref
Crossref
Rachel D. Moloney, Anthony C. Johnson, Siobhain M. O'Mahony, Timothy G. Dinan, Beverley Greenwood‐Van Meerveld & John F. Cryan. (2015) Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome. CNS Neuroscience & Therapeutics 22:2, pages 102-117.
Crossref
Crossref
G. Tabanelli, V. Verardo, F. Pasini, P. Cavina, R. Lanciotti, M.F. Caboni, F. Gardini & C. Montanari. (2016) Survival of the functional yeast Kluyveromyces marxianus B0399 in fermented milk with added sorbic acid. Journal of Dairy Science 99:1, pages 120-129.
Crossref
Crossref
Justin Sirianni, Mohab Ibrahim & Amol Patwardhan. 2015. Molecular and Cell Biology of Pain. Molecular and Cell Biology of Pain
565
611
.
Kelly Parsons, Julius Goepp, Bryan Dechairo, Elizabeth Fowler, Nathan Markward, Patrick Hanaway, Teresa Mcbride & Darryl Landis. (2014) Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The Imminent Study. Global Advances in Health and Medicine 3:3, pages 25-32.
Crossref
Crossref
Julius Goepp, Elizabeth Fowler, Teresa Mcbride & Darryl Landis. (2014) Frequency of Abnormal Fecal Biomarkers in Irritable Bowel Syndrome. Global Advances in Health and Medicine 3:3, pages 9-15.
Crossref
Crossref
H. L. DuPont. (2014) Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Alimentary Pharmacology & Therapeutics 39:10, pages 1033-1042.
Crossref
Crossref
Max Schmulson, María Victoria Bielsa, Ramón Carmona-Sánchez, Angélica Hernández, Aurelio López-Colombo, Yolanda López Vidal, Mario Peláez-Luna, José María Remes-Troche, José Luis Tamayo & Miguel Angel Valdovinos. (2014) Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome (IBS): an evidence-based review. Revista de Gastroenterología de México (English Edition) 79:2, pages 96-134.
Crossref
Crossref
M. Schmulson, M.V. Bielsa, R. Carmona-Sánchez, A. Hernández, A. López-Colombo, Y. López Vidal, M. Peláez-Luna, J.M. Remes-Troche, J.L. Tamayo & M.A. Valdovinos. (2014) Microbiota, infecciones gastrointestinales, inflamación de bajo grado y antibioticoterapia en el síndrome de intestino irritable. Una revisión basada en evidencias. Revista de Gastroenterología de México 79:2, pages 96-134.
Crossref
Crossref
Sandra Tejero-Sariñena, Janine Barlow, Adele Costabile, Glenn R. Gibson & Ian Rowland. (2013) Antipathogenic activity of probiotics against Salmonella Typhimurium and Clostridium difficile in anaerobic batch culture systems: Is it due to synergies in probiotic mixtures or the specificity of single strains?. Anaerobe 24, pages 60-65.
Crossref
Crossref
Borja S?nchez, Lorena Ruiz, Miguel Gueimonde & Abelardo Margolles. (2013) Omics for the study of probiotic microorganisms. Food Research International 54:1, pages 1061-1071.
Crossref
Crossref
Manuela Centanni, Silvia Turroni, Elena Biagi, Marco Severgnini, Clarissa Consolandi, Patrizia Brigidi & Marco Candela. (2013)
A novel combined approach based on HTF-Microbi.Array and qPCR for a reliable characterization of the
Bifidobacterium
-dominated gut microbiota of breast-fed infants
. FEMS Microbiology Letters 343:2, pages 121-126.
Crossref
Crossref